Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 1
2009 8
2010 7
2011 7
2012 15
2013 13
2014 7
2015 5
2016 8
2017 3
2018 6
2019 4
2020 5
2021 7
2022 9
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial.
Kim MC, Ahn JH, Hyun DY, Lim Y, Lee SH, Oh S, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JH, Lee SR, Kang DO, Hwang JY, Youn YJ, Jeong YH, Park Y, Kim DB, Choo EH, Kim CJ, Kim W, Rhew JY, Lee JH, Yoo SY, Ahn Y; OPTION-STEMI Investigators Gwangju, Korea; Suncheon, Korea; Jeonju, Korea; Seoul, Korea; Jinju, Korea; Wonju, Korea; Gwangmyeong, Korea; Changwon, Korea; Bucheon, Korea; Uijeongbu, Korea; Daegu, Korea; Pyeongtaek, Korea; Gangneung, Korea. Kim MC, et al. Among authors: kim db. Am Heart J. 2024 Apr 17:S0002-8703(24)00078-4. doi: 10.1016/j.ahj.2024.03.017. Online ahead of print. Am Heart J. 2024. PMID: 38641031
Dual Antiplatelet Therapy De-Escalation in Stabilized Myocardial Infarction With High Ischemic Risk: Post Hoc Analysis of the TALOS-AMI Randomized Clinical Trial.
Lee M, Byun S, Lim S, Choo EH, Lee KY, Moon D, Choi IJ, Hwang BH, Kim CJ, Park MW, Choi YS, Kim HY, Yoo KD, Jeon DS, Yim HW, Chang K; TALOS-AMI Investigators. Lee M, et al. JAMA Cardiol. 2024 Feb 1;9(2):125-133. doi: 10.1001/jamacardio.2023.4587. JAMA Cardiol. 2024. PMID: 38117483 Clinical Trial.
Long-term Effects of P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention: 3-Year Follow-up of the SMART-CHOICE Randomized Clinical Trial.
Choi KH, Park YH, Song YB, Park TK, Lee JM, Yang JH, Choi JH, Choi SH, Oh JH, Chun WJ, Jang WJ, Im ES, Jeong JO, Cho BR, Oh SK, Yun KH, Cho DK, Lee JY, Koh YY, Bae JW, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha SW, Gwon HC, Hahn JY; SMART-CHOICE Investigators. Choi KH, et al. JAMA Cardiol. 2022 Nov 1;7(11):1100-1108. doi: 10.1001/jamacardio.2022.3203. JAMA Cardiol. 2022. PMID: 36169938 Free PMC article.
Durable polymer versus biodegradable polymer drug-eluting stents in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: a post hoc analysis of the HOST-REDUCE-POLYTECH-ACS trial.
Hwang D, Lim HS, Park KW, Shin WY, Kang J, Han JK, Yang HM, Kang HJ, Koo BK, Cho YK, Hong SJ, Kim S, Jo SH, Kim YH, Kim W, Lee SY, Oh SK, Kim DB, Kim HS. Hwang D, et al. Among authors: kim db. EuroIntervention. 2022 Dec 2;18(11):e910-e919. doi: 10.4244/EIJ-D-22-00372. EuroIntervention. 2022. PMID: 36000257 Free PMC article. Clinical Trial.
98 results